E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 11/12/2008 in the Prospect News Convertibles Daily.

Bangkok Dusit to start partial tender offer for 3.75% convertibles Friday

By Angela McDaniels

Tacoma, Wash., Nov. 12 - Bangkok Dusit Medical Services PCL will begin a partial tender offer for its $124 million 3.75% convertible bonds due 2011 Friday, according to a company news release.

The offer will expire at 12 p.m. ET on Nov. 19.

The company said it expects the offer will be for up to $50 million of the convertibles, although that amount may change.

Holders will be invited to specify the clearing price they will accept.

Bangkok Dusit will accept bonds at the lowest tender prices first and then accept tenders from lowest to highest up to the clearing price, the minimum price needed to reach the size of the offer. All holders will receive the clearing price. No accrued interest will be paid.

Any convertibles repurchased will be cancelled, as will the shares reserved for the conversion of those convertibles.

The offer will be funded with cash, funds raised by the company, a financial institution loan or through a combination.

The Bangkok-based private hospital operator said repurchasing the convertibles is expected to result in cost savings and reduce potential dilution.

Macquarie Capital (Singapore) Pte. Ltd. is handling the tender (+852 2823 4628 or +852 2249 3428 or email roland.sharman@macquarie.com or richard.peel@macquarie.com).


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.